Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00196_DB00661_nanopub.RAqiN_maky2CxU19oM40YfZhnO_IC9wOhjpBEXN-vHRFI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00196_DB00661 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00196_DB00661 label "DDI between Fluconazole and Verapamil - Fluconazole may increase the serum concentration of Verapamil by decreasing Verapamil metabolism. This likely occurs via Fluconazole-mediated CYP3A4 inhibition. Monitor for changes in the therapeutic/adverse effects of Verapamil if Fluconazole is initiated, discontinued, or dose changed. [drugbank_resource:DB00196_DB00661]" assertion.
- drugbank_resource:DB00196_DB00661 identifier "drugbank_resource:DB00196_DB00661" assertion.
- drugbank_resource:DB00196_DB00661 title "DDI between Fluconazole and Verapamil - Fluconazole may increase the serum concentration of Verapamil by decreasing Verapamil metabolism. This likely occurs via Fluconazole-mediated CYP3A4 inhibition. Monitor for changes in the therapeutic/adverse effects of Verapamil if Fluconazole is initiated, discontinued, or dose changed." assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB00661 assertion.
- drugbank:DB00196 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB00661 assertion.